Co-Diagnostics Hosts Kingdom of Saudi Arabia Joint Mission CoMira for Unveiling of Long term Computerized Production Line
Seek advice from has integrated excursion of Utah headquarters and automatic production amenities forward of deliberate generation switch
(PRNewsfoto/Co-Diagnostics)
The week-long consult with and the day past’s unveiling constitute the following segment of the Corporate’s partnership with CoMira, which is designed to convey Co-Dx’s molecular diagnostics platform* and production features to the Kingdom of Saudi Arabia. The KSA delegation and different dignitaries toured the Corporate’s long run computerized PCR take a look at equipment production line, a key part of the deliberate generation switch to CoMira, which is anticipated to allow fast scaling of diagnostic take a look at manufacturing and extra environment friendly deployment of trying out answers to improve healthcare wishes in KSA and 18 different Heart Jap and Northern African international locations.
“International partnerships like the one we have fostered with CoMira reflect our belief that closing the diagnostics gap requires a collaboration between both leading-edge technology and deep local expertise,” remarked Dwight Egan, Leader Govt Officer of Co-Diagnostics. “This visit is an opportunity to demonstrate what we are building and what we intend to deliver: an integrated platform, a manufacturing capability, and a partnership model that we believe can make meaningful diagnostics more accessible across the region and beyond.”
The Co-Dx PCR platform integrates synthetic intelligence and cloud-connected outbreak surveillance features designed to improve real-time tracking of infectious illness developments. Those features are anticipated to be an element of the CoMira partnership and mirror the Corporate’s broader technique of deploying computerized, AI-enabled diagnostics infrastructure in key world markets.
The delegation tournament came about on June 17, 2026, and integrated participation from Utah state officers, business representatives, and different native leaders, reflecting the importance of the partnership to each the native innovation ecosystem and U.S.-Gulf area financial collaboration.
Tale Continues
“This visit has provided our team a direct look at the advanced manufacturing infrastructure that will underpin CoMira’s future operations in the Kingdom,” stated Ihssan Rjoob, CEO of CoMira Diagnostics. “Co-Diagnostics has built an automated platform designed for scalable, efficient production, and we are excited to translate that capability into a local manufacturing operation that will complement CoMira’s strengths in serving the healthcare needs of Saudi Arabia and the broader region.”
*The Co-Dx PCR platform (together with the PCR House®, PCR Professional®, cellular app, and all related checks) is matter to study by means of the FDA and/or different regulatory our bodies and isn’t but to be had on the market.
About Co-Diagnostics, Inc.:Co-Diagnostics, Inc., a Utah company, is a molecular diagnostics corporate that develops, manufactures and markets cutting-edge diagnostics applied sciences. The Corporate’s applied sciences are applied for checks which are designed the use of the detection and/or research of nucleic acid molecules (DNA or RNA). The Corporate additionally makes use of its proprietary generation to design explicit checks for its Co-Dx PCR at-home and point-of-care platform (matter to regulatory overview and no longer recently on the market) and to spot genetic markers to be used in packages as opposed to infectious illness.
Ahead-Having a look Statements:This press unlock incorporates forward-looking statements inside the which means of the Non-public Securities Litigation Reform Act of 1995. Ahead-looking statements may also be known by means of phrases comparable to “believes,” “expects,” “estimates,” “intends,” “may,” “plans,” “will,” “seeks,” “anticipates,” and identical expressions, or the detrimental of those phrases. Ahead-looking statements on this press unlock come with, however don’t seem to be restricted to, statements relating to: (i) the deliberate generation switch to CoMira and anticipated features of the Corporate’s computerized production line; (ii) the Corporate’s plans and expectancies relating to world commercialization via three way partnership partnerships; and (iii) the anticipated features of the Co-Dx platform, together with AI and outbreak surveillance capability. Such statements are matter to various dangers and uncertainties, together with, with out limitation: dangers associated with world operations, together with converting regulatory necessities, financial prerequisites, and geopolitical components; dangers associated with the Corporate’s dependence on three way partnership companions and different 3rd events; dangers associated with regulatory overview by means of the FDA or different regulatory government; dangers associated with the efficiency, reliability, and marketplace acceptance of the Co-Dx PCR platform; and different dangers described now and again within the Corporate’s filings with the Securities and Alternate Fee (“SEC”). Precise effects might fluctuate materially from the ones expressed or implied in those forward-looking statements. An extra description of dangers and uncertainties may also be discovered within the Corporate’s Annual Document on Shape 10-Okay filed with the Securities and Alternate Fee on March 31, 2026, and in its different filings with the SEC. The Corporate undertakes no legal responsibility to replace any forward-looking statements to mirror occasions or cases after the date of this press unlock, apart from as required by means of acceptable regulation.
Cision
